Evidence map›Paper›PMID 31409373›Full record

ArticleGenome biology2019

Screening for genes that accelerate the epigenetic aging clock in humans reveals a role for the H3K36 methyltransferase NSD1.

Daniel E Martin-Herranz, Erfan Aref-Eshghi, Marc Jan Bonder, Thomas M Stubbs, Sanaa Choufani, Rosanna Weksberg, Oliver Stegle, Bekim Sadikovic, Wolf Reik, Janet M Thornton

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 121 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Daniel E Martin-HerranzEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. dem44@ebi.ac.uk.ORCID 0000-0002-2285-3317
Erfan Aref-EshghiDepartment of Pathology and Laboratory Medicine, Western University, London, Canada.
Marc Jan BonderEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Thomas M StubbsChronomics Ltd., Cambridge, UK.
Sanaa ChoufaniGenetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, Canada.
Rosanna WeksbergGenetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, Canada.
Oliver StegleEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Bekim SadikovicDepartment of Pathology and Laboratory Medicine, Western University, London, Canada.
Wolf ReikEpigenetics Programme, The Babraham Institute, Cambridge, UK. wolf.reik@babraham.ac.uk.
Janet M ThorntonEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. thornton@ebi.ac.uk.
European Bioinformatics Institute · GBHospital for Sick Children · CAWestern University · CABabraham Institute · GB

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

backgroundEpigenetic clocks are mathematical models that predict the biological age of an individual using DNA methylation data and have emerged in the last few years as the most accurate biomarkers of the aging process. However, little is known about the molecular mechanisms that control the rate of such clocks. Here, we have examined the human epigenetic clock in patients with a variety of developmental disorders, harboring mutations in proteins of the epigenetic machinery.

resultsUsing the Horvath epigenetic clock, we perform an unbiased screen for epigenetic age acceleration in the blood of these patients. We demonstrate that loss-of-function mutations in the H3K36 histone methyltransferase NSD1, which cause Sotos syndrome, substantially accelerate epigenetic aging. Furthermore, we show that the normal aging process and Sotos syndrome share methylation changes and the genomic context in which they occur. Finally, we found that the Horvath clock CpG sites are characterized by a higher Shannon methylation entropy when compared with the rest of the genome, which is dramatically decreased in Sotos syndrome patients.

conclusionsThese results suggest that the H3K36 methylation machinery is a key component of the epigenetic maintenance system in humans, which controls the rate of epigenetic aging, and this role seems to be conserved in model organisms. Our observations provide novel insights into the mechanisms behind the epigenetic aging clock and we expect will shed light on the different processes that erode the human epigenetic landscape during aging.

Indexed as

Epigenesis, GeneticGenetic TestingAdultAgingBiological ClocksCpG IslandsDNA MethylationEntropyGenome, HumanHistone-Lysine N-MethyltransferaseHistonesHumansInfantLysineModels, GeneticSotos SyndromeHistone-Lysine N-MethyltransferaseHistonesLysineNSD1 protein, humanAgingBiological ageDevelopmental disorderDNA methylationEpigenetic clockEpigeneticsH3K36 methylationMethylation entropyNSD1Sotos syndrome

Identifiers

PMID31409373
PMCPMC6693144
OpenAlexW2967763881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.